Otsuka Holdings Co., Ltd. - Unsponsored ADR (OTCMKTS:OTSKY - Get Free Report) shares gapped up prior to trading on Wednesday . The stock had previously closed at $26.67, but opened at $27.76. Otsuka shares last traded at $27.78, with a volume of 21,034 shares.
Analyst Ratings Changes
Separately, Zacks Research upgraded Otsuka to a "strong sell" rating in a research note on Monday, August 11th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Otsuka presently has a consensus rating of "Sell".
Check Out Our Latest Research Report on OTSKY
Otsuka Stock Up 6.4%
The firm has a market cap of $30.50 billion and a PE ratio of 0.19. The firm has a 50-day moving average price of $26.61 and a two-hundred day moving average price of $25.12.
About Otsuka
(
Get Free Report)
Otsuka Holdings Co, Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Otsuka, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Otsuka wasn't on the list.
While Otsuka currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
